St Jude target Nanostim progresses with first leadless pacemaker
This article was originally published in Clinica
Executive Summary
Nanostim has taken a step closer to getting the first leadless pacemaker onto the market, after reporting findings from the first three patients implanted with its device. The company presented the early-stage results at the Heart Rhythm meeting held in Denver, Colorado, on 8-11 May.